Proximal Risk for Suicide in Adolescents
1 other identifier
observational
144
1 country
1
Brief Summary
The central hypothesis is that biometric data can continuously monitor and allow for early identification/intervention of escalating suicidal symptoms. The rationale is that improved outpatient monitoring through wearable technology can create a more objective platform to provide the ability to identify a worsening condition and utilize patient-specific just-in-time therapeutics developed with mental health providers for suicidal adolescents.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2023
CompletedFirst Submitted
Initial submission to the registry
April 17, 2024
CompletedFirst Posted
Study publicly available on registry
May 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedAugust 14, 2025
August 1, 2025
2 years
April 17, 2024
August 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Heart rate variability and Suicidality
Prediction of Suicidality outcome measured by the Columbia Suicide Severity scale (higher score means more suicidal)
Four times daily up to one week
Heart rate variability and Suicidality
Prediction of Suicidality outcome measured by the High Frequency Heart Rate Variability Metric (lower score means less parasympathetic response)
Four times daily up to one week
Study Arms (1)
Suicidal Adolescent
he study will enroll subjects aged 13-17 years admitted with a chief complaint of acute suicidality or attempt. Patients will undergo physiologic and biometric monitoring in the hospital with a wrist-wearable device and chest wall ECG leads. They will undergo serial assessment four times daily to gather data regarding their activities, affect, and suicidality.
Interventions
Wearable wrist device that collects Photoplethysmography, accelerometer data among other parameters.
Eligibility Criteria
All suicidal adolescents presenting with acute suicidality.
You may qualify if:
- subjects aged 13-17 years
- presenting to the ED or inpatient psychiatric unit with a chief complaint of acute suicidality or attempt.
You may not qualify if:
- acutely agitated patients per the treating physician
- adolescents who are not medically cleared from a suicide attempt
- no legally authorized representative available to provide consent
- parental report of significant developmental delay or autism diagnosis
- prisoners
- non-English speaking.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oregon Health and Science Universitylead
- Analog Device, Inc.collaborator
Study Sites (1)
OHSU
Portland, Oregon, 97239, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Sheridan, MD
Oregon Health and Science University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 17, 2024
First Posted
May 6, 2024
Study Start
June 15, 2023
Primary Completion
June 30, 2025
Study Completion (Estimated)
July 1, 2026
Last Updated
August 14, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share